Ad is loading...
PMBPX
Price
$47.63
Change
+$0.66 (+1.41%)
Updated
Nov 22 closing price
RPTIX
Price
$113.98
Change
+$1.08 (+0.96%)
Updated
Nov 22 closing price
Ad is loading...

PMBPX vs RPTIX

Header iconPMBPX vs RPTIX Comparison
Open Charts PMBPX vs RPTIXBanner chart's image
Principal MidCap R5
Price$47.63
Change+$0.66 (+1.41%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$113.98
Change+$1.08 (+0.96%)
VolumeN/A
CapitalizationN/A
PMBPX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMBPX vs. RPTIX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBPX is a Buy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.8B vs. PMBPX (29.9B). RPTIX pays higher dividends than PMBPX: RPTIX (0.18) vs PMBPX (0.00). PMBPX was incepted earlier than RPTIX: PMBPX (24 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than RPTIX: PMBPX (0) vs RPTIX (500000). PMBPX annual gain was more profitable for investors over the last year : 29.97 vs. RPTIX (16.26). PMBPX return over 5 years is better than : 52.26 vs. RPTIX (17.97).
PMBPXRPTIXPMBPX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD25.62213.696187%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets29.9B31.8B94%
Annual Yield % from dividends0.000.18-
Returns for 1 year29.9716.26184%
Returns for 3 years7.46-12.19-61%
Returns for 5 years52.2617.97291%
Returns for 10 years107.91N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SES0.310.01
+1.93%
SES AI Corp
MTX83.390.96
+1.16%
Minerals Technologies
DOX85.670.47
+0.55%
Amdocs Limited
PIK2.21-0.02
-0.90%
Kidpik Corp
OTLK5.03-0.10
-1.95%
Outlook Therapeutics